Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.
Other Developments
A curated list of other prominent stories from this day.
4:01 PMStat News
STAT+: Tau in the spotlight at Alzheimer’s conference
Summary
Researchers at the Alzheimer’s conference shifted attention toward tau biology and tau-targeting therapies, alongside updates on methods to deliver drugs across the blood-brain barrier. The reporting flags these as emerging focal points as the field looks beyond amyloid-only strategies.
Why it matters
A tau-and-delivery pivot could reset Alzheimer’s R&D priorities and determine whether the next wave of drugs produces meaningful clinical improvement.
The $360 Billion Market that Medicine Got Wrong for 20 Years
Summary
Menopause and broader midlife women's health have been underfunded and under-treated for decades despite affecting roughly half the population and driving large productivity losses. Celebrities, venture-backed startups, and a loosening of FDA-era stigma around hormone therapy are now pulling the category into a fast-growing, $360 billion women's health market, even as low-evidence wellness offerings proliferate.
Why it matters
Menopause care is turning from a neglected clinical gap into a major healthcare market, and the quality bar set now will shape outcomes, costs, and workplace productivity.